QuantHealth

Israel - Tel Aviv

• 31/08/2023
• Series A
• $15,000,000

QuantHealth is an AI company conducting patient-centric drug simulations to accelerate and de-risk drug development. Over 90% of drugs in clinical development stage fail to reach the market, which accumulates to a $45B/year direct lost to the pharma and biotech industry. Our platform allows our pharma and biotech partners to rapidly run thousands of variations of their clinical trials to optimize the trial design and significantly increase the probability of trial success, all while enabling discovery of new clinical opportunities and optimization strategies. QuantHealth has one the largest integrated datasets that spans the clinical, pharmacological and biological domains together with a proprietary AI platform that can predict patient-response to both approved and novel therapies.

Related People

Orr InbarCo Founder

Israel - ND

I'm an entrepreneur and software/AI professional with over 10 years of leadership experience helping small to mid-sized startups in Israel and the US to grow, innovate, scale, and deliver. Domain expertise in healthcare, enterprise services and SaaS.

LinkedIn https://www.linkedin.com/in/orr-inbar-93346158/